DAVID M WEINSTOCK, MD
Osteopathic Medicine at Brookline Ave, Boston, MA

License number

Massachusetts 234387

Personal information

See more information about DAVID M WEINSTOCK at radaris.com

Name

Address

Phone

David Weinstock, age 57

43 Clapp St, Norton, MA 02766

David Weinstock, age 51

6 Moss Hill Rd, Jamaica Plain, MA 02130

David Weinstock, age 57

8 Carmen Cir, Medfield, MA 02052

(508) 612-3078

David Weinstock

17 Thoreau Rd, Lexington, MA 02420

David Weinstock

113 Stedman St, Brookline, MA 02446

Professional information

See more information about DAVID M WEINSTOCK at trustoria.com

Regional Manager-Coinstar Inc.

Position:

Regional Manager-Northeast at Coinstar

Location:

Greater Boston Area

Industry:

Consumer Services

Work:

Coinstar since Apr 2010 - Regional Manager-Northeast Brinks Inc. Dec 1995 - Apr 2010 - District Manager Brinks Inc. Aug 2000 - Sep 2002 - Branch Manager UPS 1989 - 1995 - Account Exec

Education:

Northeastern University 1987 - 1991
BS, International Business

Skills:

Operations Management, Team Building, P&L Management, Forecasting, Process Improvement, Cross-functional Team Leadership, Leadership, Strategy, Strategic Planning, CRM, Income Statement, Training, Inventory Management, Logistics, Sales Management, New Business Development, Customer Satisfaction, Supply Chain, Sales Operations, Budgets, Account Management, Contract Negotiation, Pricing, Management

Dr. David M Weinstock, Boston MA - MD (Doctor of Medicine)

Specialties:

Oncology, Infectious Disease Medicine

Age:

Address:

DANA-FARBER CANCER INSTITUTE
450 Brookline Ave, Boston 02215
(617) 632-5117 (Phone)
Boston Office
450 Brookline Ave, Boston 02215
(617) 632-3000 (Phone)

Languages:

English

Hospitals:

DANA-FARBER CANCER INSTITUTE
450 Brookline Ave, Boston 02215
Boston Office
450 Brookline Ave, Boston 02215
Brigham and Women's Hospital
75 Francis St, Boston 02115
Massachusetts General Hospital
55 Fruit St, Boston 02114
North Shore Medical Center - Salem Hospital
81 Highland Ave, Salem 01970

Education:

Medical School
George Washington University School Of Medicine
Graduated: 1997
Ny Hospital Cornell
Graduated: 2000
Meml Sloan Kettering Canc Center

David Weinstock

Location:

Greater Boston Area

Industry:

Hospital & Health Care

Skills:

Workshop Facilitation, Healthcare Information Technology, EHR, Strategy, Healthcare, Business Analysis, CRM, Process Improvement, SDLC, Enterprise Software, Management

David Marc Weinstock, Boston MA

Specialties:

Internal Medicine, Infectious Disease, Hematology, Hematology & Oncology, Medical Oncology

Work:

Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215 Memorial Sloan-Kettering
1275 York Ave, New York, NY 10065 Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115

Education:

George Washington University (1997)

Crlf2 In Precursor B-Cell Acute Lymphoblastic Leukemia

US Patent:

2012028, Nov 8, 2012

Filed:

Nov 24, 2010

Appl. No.:

13/508395

Inventors:

David Weinstock - Jamaica Plain MA, US
Akinori Yoda - Brookline MA, US

Assignee:

DANA-FARBER CANCER INSTITUTE, INC. - Boston MA

International Classification:

C07K 16/30, C12N 15/12, C12N 15/63, C12N 5/10, A61P 35/02, A61K 31/7088, C12Q 1/68, C07K 14/705, A61K 39/395

US Classification:

4241381, 530350, 536 235, 4353201, 5303877, 4241781, 514 44 A, 435 612, 5303917, 435369, 435358, 435325

Abstract:

The invention relates to cytokine receptor-like factor 2 (CRLF2), and particularly certain mutant forms of CRLF2, as prognostic and therapeutic targets in precursor B-cell acute lymphoblastic leukemia (B-ALL). Mutant CRLF2 with a Phe232-Cys (F232C) mutation is overexpressed and constitutively activates STAT5 in a subset of B-ALL patients with particularly poor prognosis. Methods and compositions useful for identifying, inhibiting expression, and inhibiting activity of the mutant CRLF2 are provided. Also provided are methods and compositions useful for treating B-ALL.